Gamifant for Primary Hemophagocytic Lymphohistiocytosis

February 13, 2019

Gamifant

Gamifant (emapalumab-lzsg, Sobi)

Indications: patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.

Dosage: 1 mg/kg as an intravenous infusion over 1 hour twice per week; Administer dexamethasone concomitantly with GAMIFANT.

Contraindications:None

Click here for more prescribing information